Pericarditis aguda asociada a mesalazina

Abstract

Among the commonly drugs used for the treatment of inflammatory bowel disease (IBD) we found the 5-ASA and among them there is mesalazine. Despite having a good tolerability profile and a low rate of adverse reactions, which are usually mild, they also include severe reactions such as cardiovascular ones. Although it is rare, pericarditis associated with the use of mesalazine is an entity that must be taken into account in these patients. The onset of pleuritic chest pain should alert physicians for possible complications.